PeptideDB

PS372424 hydrochloride 1596362-29-6

PS372424 hydrochloride 1596362-29-6

CAS No.: 1596362-29-6

PS372424HCl, a three-amino acid (AA) fragment of CXCL10, is a specific human CXCR3 agonist/activator with anti-inflammat
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

PS372424 HCl, a three-amino acid (AA) fragment of CXCL10, is a specific human CXCR3 agonist/activator with anti-inflammatory activity. PS372424 HCl inhibits T cell migration in models of arthritis inflammation.

Physicochemical Properties


Molecular Formula C33H45CLN6O4
Molecular Weight 625.201206922531
Exact Mass 624.319
CAS # 1596362-29-6
Related CAS # PS372424;914291-61-5
PubChem CID 117064650
Appearance White to off-white solid powder
Hydrogen Bond Donor Count 5
Hydrogen Bond Acceptor Count 5
Rotatable Bond Count 13
Heavy Atom Count 44
Complexity 970
Defined Atom Stereocenter Count 2
SMILES

Cl.O=C([C@H](CCC/N=C(\N)/N)NC([C@@H]1CC2C=CC=CC=2CN1C(CCC(C1C=CC=CC=1)=O)=O)=O)NCC1CCCCC1

InChi Key XHGSJQNAEULTAR-DHBRAOIWSA-N
InChi Code

InChI=1S/C33H44N6O4.ClH/c34-33(35)36-19-9-16-27(31(42)37-21-23-10-3-1-4-11-23)38-32(43)28-20-25-14-7-8-15-26(25)22-39(28)30(41)18-17-29(40)24-12-5-2-6-13-24;/h2,5-8,12-15,23,27-28H,1,3-4,9-11,16-22H2,(H,37,42)(H,38,43)(H4,34,35,36);1H/t27-,28-;/m0./s1
Chemical Name

(3S)-N-[(2S)-1-(cyclohexylmethylamino)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-2-(4-oxo-4-phenylbutanoyl)-3,4-dihydro-1H-isoquinoline-3-carboxamide;hydrochloride
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets Human CXCR3
ln Vitro In U87-CXCR3-A cells, PS372424 (100 ng/mL) raises p-Erk1 and p-Erk2 after 5 minutes of stimulation[1]. CCR5 on CXCR3+ T cells, but not on CXCR3- T cells, is phosphorylated in response to concentration when exposed to PS372424 (10-200 nM; 30 min)[2]. At an IC50 of 42±21 nM, PS372424 competes with radiolabeled CXCL10 for binding to membranes made from HEK293/CXCR3 Gqi5 cells[3].
Cell Assay Western Blot Analysis[2]
Cell Types: CXCR3+ T cells and CXCR3- T cells
Tested Concentrations: 10, 50, 100, or 200 nM
Incubation Duration: 30 minutes
Experimental Results: Caused a concentration-dependent phosphorylation of CCR5 on CXCR3+ T cells. Did not result in phosphorylation of CCR5 on CXCR3- T cells.
References

[1]. The role of CXCR3/LRP1 cross-talk in the invasion of primary brain tumors. Nat Commun. 2017 Nov 17;8(1):1571.

[2]. Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation. Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):4598-603.

[3]. Identification of CXCR3 receptor agonists in combinatorial small-molecule libraries. Biochem Biophys Res Commun. 2006 Oct 13;349(1):221-8.


Solubility Data


Solubility (In Vitro) DMSO: 250 mg/mL (399.87 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.08 mg/mL (3.33 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.08 mg/mL (3.33 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.08 mg/mL (3.33 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.5995 mL 7.9974 mL 15.9949 mL
5 mM 0.3199 mL 1.5995 mL 3.1990 mL
10 mM 0.1599 mL 0.7997 mL 1.5995 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.